Search Results 21-30 of 16812 for Purine
receptor, and cladribine, a purine nucleoside analogue, are currently. approved for secondary progressive MS (SPMS). None of these medications. fully halt or ...
... purine analog and/or an alkylating agent); During Phase II: All patients with relapsed disease will be eligible if they have received a minimum of 1 prior ...
Relapsed or de novo disease if deemed medically unfit for therapy with a purine nucleoside analog;. Because there is no recognized standard of care for ...
Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you ...
Probenecid is used in the treatment of chronic gout or gouty arthritis. These conditions are caused by too much uric acid in the blood. The medicine works by ...
Bats play an important role in many ecosystems around the world. They are a major predator of night-flying insects, including pests that cost farmers ...
This disease mimics gout, causing sudden, painful swelling in one or more joints. Treatments can reduce the pain and improve joint function.
Cytotoxic anticancer therapy (e.g., alkylating agents, anti-metabolites, purine analogues) or any other systemic anticancer therapy within 2 weeks of study ...
Departments and specialties. Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, ...
Participation eligibility · Must have been treated with one of the following in first and/or second line: a purine analog-containing regimen · Females of ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.